Skip to main content
. 2018 Oct 25;20(4):505–512. doi: 10.1080/15384047.2018.1537576

Table 1.

Demographic characteristics of patients with RCC.

Variable All Metastasis-free group Metastatic group
Number, n (%) 69 58 (84.1%) 11 (15.9%)
Age (y) 57.5 ± 11.1 57.1 ± 11.6 59.7 ± 7.8
Gender      
 Male, n (%) 47 (68.1%) 40 (68.9%) 7 (63.6%)
 Female, n (%) 22 (31.9%) 18 (31.1%) 4 (36.4%)
Pathological type, n (%)      
 Clear-cell carcinoma 59 (85.5%) 50 (86.2%) 9 (81.8%)
 Papillary carcinoma 5 (7.2%) 4 (6.9%) 1 (9.1%)
 Chromophobe carcinoma 4 (5.8%) 3 (5.2%) 1 (9.1%)
 Eosinophilic tumor 1 (1.5%) 1 (1.7%) 0 (0%)
Pathological grading      
 I 8 (11.6%) 7 (12.1%) 1 (9.1%)
 I-II 3 (4.3%) 3 (5.2%) 0 (0%)
 II 49 (71.1%) 40 (69.0%) 9 (81.8%)
 II-III 6 (8.7%) 6 (10.3%) 0 (0%)
 III 3 (4.3%) 2 (3.4%) 1 (9.1%)
TNM staging      
 T1 41 (59.4%) 38 (65.5%) 3 (27.3%) a,b
 T2 25 (36.2%) 18 (31.1%) 7 (63.6%) a,b
 T3 2 (2.9%) 1 (1.7%) 1 (9.1%)
 T4 1 (1.5%) 1 (1.7%) 0 (0%)
 N0 68 (98.5) 58 (100%) 10 (90.9%)
 N1 1 (1.5%) 0 (0%) 1 (9.1%)
 M0 69 (100%) 58 (100%) 11 (100%)
 M1 0 (0%) 0 (0%) 0 (0%)
Surgical treatments      
 Radical nephrectomy 26 (37.7%) 17 (29.3%) 9 (81.8%) a,b
 Partial nephrectomy 43 (62.3%) 41 (70.7%) 2 (18.2%) a,b

Data presented as mean ± SD or n (%) and P < 0.05 was considered statistically significant.

a P < 0.05 vs. All; b P < 0.05 vs. Metastasis-free group.